Supplementary Figure S5 from Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO Study

<p>Baseline expression of TLS-signature for response groups. Average expression of a TLS signature described by Cabrita and colleagues (Nature, 2020) on baseline bulk RNA sequencing samples for responders (blue; ≤ypT1N0) and non-responders (orange; ypT2-4aNx or ypTxN1-3).</p>

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας:	Chantal F. Stockem (19663331) (author)
Άλλοι συγγραφείς:	Alberto Gil-Jimenez (19663325) (author), Hamza Ali (22247032) (author), Jeroen van Dorp (19663316) (author), Nick van Dijk (22247035) (author), Maurits L. van Montfoort (19663343) (author), Maartje Alkemade (15120047) (author), Annegien Broeks (15049023) (author), Iris M. Seignette (16797655) (author), Erik Hooijberg (16797661) (author), Wim Brugman (19663328) (author), Rhianne Voogd (22247038) (author), Bas W.G. van Rhijn (19663334) (author), Laura S. Mertens (19663337) (author), Jeantine M. de Feijter (22247041) (author), Niven Mehra (15011036) (author), Antoine G. van der Heijden (19663340) (author), Richard P. Meijer (22247044) (author), Britt B.M. Suelmann (22247047) (author), Wouter Scheper (22247050) (author), Lodewyk F.A. Wessels (15037422) (author), Daniel J. Vis (19663346) (author), Michiel S. van der Heijden (19663349) (author)
Έκδοση:	2025
Θέματα:	Cancer Tumor Biology Cancer Detection and Diagnosis Immuno-oncology Biomarkers Genitourinary Cancers Bladder cancer Immunotherapy Checkpoint blockade Tumor Microenvironment Immune cells and the microenvironment
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Supplementary Figure S5 from Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO Study

Παρόμοια τεκμήρια